Anti-COF-01 Raptamer-drug conjugates (Champions Oncology/Fannin)

N/A

Report date: 2026/01/27 16:11:06

Base Information

Drug NameAnti-COF-01 Raptamer-drug conjugates (Champions Oncology/Fannin)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer > Raptamer-drug conjugates
Mechanisms of ActionAnti-Cofilin 1
TargetsCofilin 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFannin Partners LLC (d/b/a Fannin Innovation Studio)
China Registration ClassN/A

Develop Information

Active CompaniesFannin Innovation StudioChampions Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A